Entera Bio Ltd. WT EXP 062723 ENTXW

$ 0.0 0.0%

Quarterly report 2024-Q3
added 12-21-2024

Entera Bio Ltd. WT EXP 062723 Financial Statements 2011-2024 | ENTXW

Annual Financial Statements Entera Bio Ltd. WT EXP 062723

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	-	1.73 M	-	-	-	-	-	-	-	-	-	-	-
Shares	29 M	28.8 M	26.1 M	18.4 M	-	-	-	-	-	-	-	-	-
Historical Prices	-	0.06	-	-	-	-	-	-	-	-	-	-	-
Net Income	-8.89 M	-13.1 M	-12.2 M	-11.2 M	-	-	-	-	-	-	-	-	-
Revenue	-	134 K	571 K	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	101 K	373 K	300 K	-	-	-	-	-	-	-	-	-
Gross Profit	-	33 K	198 K	65 K	-	-	-	-	-	-	-	-	-
Operating Income	-8.89 M	-13 M	-12.2 M	-11.2 M	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-8.84 M	-13 M	-12.2 M	-11.1 M	-	-	-	-	-	-	-	-	-
Operating Expenses	8.89 M	13 M	12.4 M	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	4.43 M	7.25 M	5.69 M	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Entera Bio Ltd. WT EXP 062723

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	37.6 M	37.1 M	36.7 M	35.5 M	28.8 M	28.8 M	28.8 M	28.8 M	28.8 M	28.8 M	28.8 M	28.8 M	28.7 M	24.7 M	21.9 M	21.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-3.02 M	-2.14 M	-2.02 M	-	-2.38 M	-2.32 M	-2.19 M	-	-3.07 M	-3.18 M	-3.78 M	-	-3.21 M	-2.58 M	-2.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	42 K	57 K	-	-	-	-	-	-	8 K	44 K	68 K	-	140 K	109 K	157 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	42 K	48 K	-	-	-	-	-	-	6 K	33 K	54 K	-	65 K	99 K	73 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	9 K	-	-	-	-	-	-	2 K	11 K	14 K	-	75 K	10 K	84 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-3.02 M	-2.16 M	-2.06 M	-	-2.39 M	-2.33 M	-2.21 M	-	-2.86 M	-3.25 M	-3.84 M	-	-3.22 M	-2.57 M	-2.34 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-2.2 M	-	-2.82 M	-3.22 M	-3.82 M	-	-3.18 M	-2.55 M	-2.33 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	3.02 M	2.17 M	-	-	2.39 M	2.33 M	2.21 M	-	2.87 M	3.26 M	3.85 M	-	3.3 M	2.58 M	2.42 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	1.54 M	1.09 M	-	-	1.03 M	1.14 M	1.29 M	-	1.46 M	1.88 M	2.17 M	-	1.54 M	1.36 M	1.31 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency